Upload
michel-triffaux
View
439
Download
3
Embed Size (px)
Citation preview
Improvements
in Brain Tumor SurgeryDr. M. Triffaux
Dr. V. Marneffe
Dr. A. Tyberghien
Dr. O. Lermen
Improvements in Brain Tumor Surgery
• Advanced neuronavigation
– Electromagnetic navigation
– Fiber tracking MRI
– Neuro Endoscopy
• Fluorescence guided resection
• Integrat
Hemostasis in neurosurgery
• Hemostasis: key importance for successful surgery• Prevention of bleeding is the best solution• Hemostatis methods:
– Mechanical– Chemical– Electrical
Prevention of bleeding
• Position of the patient gravity is the best allied– head position
Prevention of bleeding
• Minimize the risk of vessel injury– Adequate dissection techniques
• Avoid to pulling tissue• Maintaining a good visualization
– Control powered instrument (drills, Cusa,…)– atraumatic suction tip
Hemostasis in NS
• Mechanical– Horsley’s bone wax– muscle stamps,– compression,– ligature, – clamps,– clip: Cushing’s silver clips– cottonoid ,
Hemostasis in NS
• Chemical– Historic: alum, copper sulfate, ferric chloride,
Zenker solution
Hemostasis in NS
• Chemical– Historic: – Organic: oxydised cellulose, gelatin,collagen,
autolog fibrin( plasmatic centrifugation)
surgicel spongostan surgiflow
original
fibrillar
Hemostasis in NS
• Use of heat to control bleeding has been described throughout human history
• Electro surgeryProcess of electrocoagulation utilizes heat generated from an electrical current that flows through a metal probe to locally burn
Electrosurgery in neurosurgery
• 1926 H. Cushing / W. Bovie first removal of braintumor using electrocautery
Electrosurgery in neurosurgery
• 1926 H. Cushing / W. Bovie• 1940 J. Greenwood
introduced the concept of two point coagulation,and the bipolar
coagulation was invented.
Electrosurgery in neurosurgery
• 1926 H. Cushing / W. Bovie• 1940 J. Greenwood• 1955 L. Malis : first commercial bipolarcoagulator
Electrosurgery in NS
Monopolar Bipolar
Electrosurgery in NS
Monopolar Bipolar
But recurrent problems• Carbonization, charring required cleaning• Thermic lesion surround damage• Sticking adhesion with
tissue• get out to clean get in: reorientation• Time consuming • Coagulation failure• Frustration and fatigue for the operator
Solutions
• Generator HF computer regulation output
types of waves
Solutions
• Generator HF
Solutions
• Irrigation manual needs assistanceautomaticadjustable fluid pressureadjustable flowsolutions: PL, mannitol,
pump
Solutions
• Material of the tip:titanium, gold, stainless steel
• Coating of the tip:PTFE like Teflon
but no miracle solution
Active Heat Transfer technology
• Old principle 1942
Now available with minimal profile: Isocool forceps
Heat measurement
In vitro studies
Y. Arakawa and N. Hashimoto StudyJpn J Neurosurg (Tokyo) 14 : 698-705, 2005
Y. Arakawa and N. Hashimoto StudyJpn J Neurosurg (Tokyo) 14 : 698-705, 2005
Y. Arakawa and N. Hashimoto StudyJpn J Neurosurg (Tokyo) 14 : 698-705, 2005
Y. Arakawa and N. Hashimoto StudyJpn J Neurosurg (Tokyo) 14 : 698-705, 2005
My personal experience
• Using 1 and 0.5 mm
My personal experience
• Procedure :– Vascular – Intracranial tumor– Spine tumor– Cerebello pontine angle
Personal experience
• What I do with Iso Cool– More accuracy– More efficiency– More visibility– Less risk– No irrigation– Time-saving
Illustration 1
Illustration 2
Illustration 3
Illustration 4
Personal experience
• Limits– Cost single use (300 €)– Profile
– Not easy to do without it if you have used it
Advanced neuronavigation
• Electromagnetic Navigation
• Fiber tracking MRI
• Neuronavigation– Optical system
camera tracking instruments
– Electromagnetic system single coil gives the position in a electromagnetic
field
Electromagnetic Navigation
Electromagnetic Navigation• Optical system • Electromagnetic tracking
Electromagnetic Navigation• Optical system • Electromagnetic tracking
Electromagnetic Navigation• Optical system • Electromagnetic tracking
Electromagnetic Navigation• Optical system • Electromagnetic tracking
• Advantages– No single use– No metal interference
• Limits– Loss of camera’s line of
sight
– Smal, non invasive– No calibration– Flexible probe
– Fero magnetic disturbence– Single use
NeuroEndoscopy in Oncology
Ventriculoscopy Pituitary Key hole surgery
• In ventricular and paraventricular tumor management
• In Endoscopic Third Ventriculostomy (ETV)
– In the same time of supratentorial procedure
– in management of hydrocephalus from posterior fossa tumor
Ventriculoscopy in Oncology
• Rigid
• Flexible
Ventriculoscope
• Image Guided surgery– Choice of the best entry point and the best
trajectory– Endoscope tracking per operative
Advantages of the rigid scope
• Image Guided surgery• Endoscope stability
– Pneumatic arm– microdriver
Advantages of the rigid scope
• Image Guided surgery• Endoscop stabilisation • Higher quality
– optical resolution– trocars: multiple channels
Advantages of the rigid scope
CaseN°
Sex/age(yrs)
location Histiologicaldiagnose
ETV Further therapy
1 M / 69 3rd V. ant. Pineocytoma II Y No
2 F / 41 3rd V. ant.. Arachnoid cyst Y No
3 F / 72 Occ. paraV. Glioblastoma N Radiation
4 M / 35 3rd V. ant. Dermoid cyst N No 5 M / 21 3rd V. post Germinoma N Radiation
Chemotherapy6 F / 16 Thalamic Astrocytoma III Y Open surgery
Clinical data 2003/2005
• 21 yrs , recent diplopia
• CT MR imaging: pineal tumor whithout hydrocephalus
• Pet methionine: +
• Blood fetoproteine , HCG: nl < 1 mUI/ml
• CSF fetoproteine: nl, HCG: 3 mUI/ml
Case N° 5
Case N° 5
• Biopsy diagnosis: germinoma
• Treatment: chemotherapy & radiotherapy
2 cycles carbo/ etoposide / Ifosfamide40 Gy radiotherapy
Case N° 5
Case N° 5
Initial MR Post multimodal therapy
Case N° 6
• 16 yrs , Parinaud’s syndrome
• CT MR imaging: left thalamic mass
hydrocephalus
• Pet FDG: – Pet methionine: +
Case N° 6
CT Pet FDG MR Pet met.
Case N° 6
J10 post biopsy & ETVPre operative
Case N° 6
• Biopsy diagnosis: astrocytoma III
• Treatement: conventional surgery
astrocytoma III confirmed
Case N° 6
• Acute hydrocephalus needs treatement:– External Ventricular drainage– VP shunt– ETV
• In pediatric series: – Majority of the authors advocate ETV prior to
definitive surgery– Some others do not justify routine
preoperative ETV• In adult patients: there is no specific data
Hydrocephalus from P-fossa tumor
CaseN°
s/age ICP Symp
ETV diagnose Open surgery
1 M/46 Y pre Lung metastase Y , radiation
2 F/22 Y pre Medulloblastoma Y , chemo + radiation
3 M/45 Y pre Ependymome II Y
4 M/55 Y pre Gliome II Y
5 F/34 Y pre Melanocytoma Y
6 F/39 Y pre Neurinoma VIII Y
7 M/23 N post cavernoma Y
8 F/56 Y single Breast mets. (3) palliatif
Clinical data in adult population
• GA, supine position
• ETV with neuroballon
• Insertion of a ventricular reservoir
• Monitoring ICP 24h-48h with butterfly needle
without ventricular drainage
Surgical procedure
• Complication: 1 infection (case 8: palliative)
resolved with antiobiotherapy
• No shunt
• No CSF leak after posterior fossa surgery
Out come
Fiber tracking
Fiber tracking
Fiber tracking
Fiber tracking
Fiber tracking
Fluorescence guided resection
COO -
NH 3 +CH 2C
CH 2
CH 2
O
HC
N
NH
VM
M
P
MP
V
M
CH
N
CH
NH
HC
5-aminolevulinic acid Protoporphyrin IX
Enzymes ofheme biosynthesis
Intratumoral synthesis
Multicenter, Randomized, Balanced, Parallel, Controlled, Phase III Study: Fluorescence-Guided Surgery
Using 5-ALA
Patients with malignant gliomas• Surgical candidates• Tumor potentially resectable• Karnofsky Index ≥ 70• Age 18 - 75• Primary surgery• Informed consent
“White light group”Conventional microsurgery
+Radiotherapy
“ALA group”Fluorescence-guided
resection +Radiotherapy
Sponsor: Medac, Germany
n (%) 139 (100) 131 (100)
≤ 55 years (%) 45 (32) 43 (33)> 55 years (%) 94 (68) 88 (67)Median (years) 60 59
“Low” [ 70, 80 ] (%) 28 (20) 31 (24) “High” [ 90, 100 ] (%) 111 (80) 100 (76)
No (%) 65 (47) 54 (41)Yes (%) 74 (53) 77 (59)
WHO °III (%) 4 (3) 5 (4)WHO °IV (%) 135 (97) 126 (96)
ALA WL
Demographic Characteristics: Intent to Treat
Age
KPS
“Eloquent”
Histology
Complete Resections on Early Postoperative MRI
0
25
50
75
100
Perc
enta
ge
ALA WL
35%47/131
p < 0.0001chi2
65%90/139
139 104 59 28 168
131 85 28 13 75
Progression-Free Survival (Intent to Treat)
Stummer et al. Lancet Oncol. 2006;7:392-401.
Prog
ress
ion-
free
surv
ival
(%)
100
90
80
70
60
50
40
30
20
10
0
Log rankp = 0.0078
5-aminolevulinic acid
White light
Time (months)0 3 6 9 12 15
Numbers at risk5-aminolevulinic acidWhite light
Fluorescence guided resection
Advanced Neurosurgery